|
|
|
Volumn 23, Issue 3, 2007, Pages 260-263
|
|
Apoptotic effect of the combined treatment of engineered antibody with paclitaxel on BT474 cells
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBODY;
ANTINEOPLASTIC AGENT;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
PACLITAXEL;
APOPTOSIS;
ARTICLE;
CELL CYCLE;
CELL CYCLE G1 PHASE;
CELL PROLIFERATION;
DRUG EFFECT;
FLOW CYTOMETRY;
GEL MOBILITY SHIFT ASSAY;
HUMAN;
IMMUNOLOGY;
METABOLISM;
TUMOR CELL LINE;
ANTIBODIES;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
CELL CYCLE;
CELL LINE, TUMOR;
CELL PROLIFERATION;
ELECTROPHORETIC MOBILITY SHIFT ASSAY;
FLOW CYTOMETRY;
G1 PHASE;
HUMANS;
NF-KAPPA B;
PACLITAXEL;
RECEPTOR, ERBB-2;
|
|
EID: 65849490848
PISSN: 10078738
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
